APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 6

Compare research editions
View pricing & licenses

Selected research

Industry Research

Histone Deacetylase 6 Industry Research Report 2026

19 December 2025120 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 6 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 6 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 6 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 6 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 6 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 6 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Histone Deacetylase 6 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Histone Deacetylase 6 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 6 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Histone Deacetylase 6 include Merck & Co Inc, SK Biopharmaceuticals Co Ltd, Sigma-Tau SpA, Shuttle Pharmaceuticals LLC, Quimatryx SL, OnKure Inc, Millennium Pharmaceuticals Inc, Medivir AB and Karus Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Histone Deacetylase 6 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Histone Deacetylase 6 Market by Company

Merck & Co Inc

SK Biopharmaceuticals Co Ltd

Sigma-Tau SpA

Shuttle Pharmaceuticals LLC

Quimatryx SL

OnKure Inc

Millennium Pharmaceuticals Inc

Medivir AB

Karus Therapeutics Ltd

Kancera AB

HitGen LTD

Curis Inc

Chong Kun Dang Pharmaceutical Corp

Celgene Corp

Histone Deacetylase 6 Segment by Type

ACY-738

Citarinostat

CKD-504

HG-3001

MPT-0B291

Ricolinostat

Others

Histone Deacetylase 6 Segment by Application

CNS Lymphoma

Inflammation

Colon Cancer

Huntington Disease

Others

Histone Deacetylase 6 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 6 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 6 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 6.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Histone Deacetylase 6 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Histone Deacetylase 6 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Histone Deacetylase 6 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Histone Deacetylase 6 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Histone Deacetylase 6 Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Histone Deacetylase 6 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Histone Deacetylase 6 Revenue of Manufacturers (2021-2026) Table 9. Global Histone Deacetylase 6 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Histone Deacetylase 6 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Histone Deacetylase 6 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Histone Deacetylase 6, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Histone Deacetylase 6, Product Type & Application Table 14. Global Histone Deacetylase 6 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Histone Deacetylase 6 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck & Co Inc Company Information Table 19. Merck & Co Inc Business Overview Table 20. Merck & Co Inc Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Merck & Co Inc Histone Deacetylase 6 Product Portfolio Table 22. Merck & Co Inc Recent Developments Table 23. SK Biopharmaceuticals Co Ltd Company Information Table 24. SK Biopharmaceuticals Co Ltd Business Overview Table 25. SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Product Portfolio Table 27. SK Biopharmaceuticals Co Ltd Recent Developments Table 28. Sigma-Tau SpA Company Information Table 29. Sigma-Tau SpA Business Overview Table 30. Sigma-Tau SpA Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sigma-Tau SpA Histone Deacetylase 6 Product Portfolio Table 32. Sigma-Tau SpA Recent Developments Table 33. Shuttle Pharmaceuticals LLC Company Information Table 34. Shuttle Pharmaceuticals LLC Business Overview Table 35. Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Product Portfolio Table 37. Shuttle Pharmaceuticals LLC Recent Developments Table 38. Quimatryx SL Company Information Table 39. Quimatryx SL Business Overview Table 40. Quimatryx SL Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Quimatryx SL Histone Deacetylase 6 Product Portfolio Table 42. Quimatryx SL Recent Developments Table 43. OnKure Inc Company Information Table 44. OnKure Inc Business Overview Table 45. OnKure Inc Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. OnKure Inc Histone Deacetylase 6 Product Portfolio Table 47. OnKure Inc Recent Developments Table 48. Millennium Pharmaceuticals Inc Company Information Table 49. Millennium Pharmaceuticals Inc Business Overview Table 50. Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Millennium Pharmaceuticals Inc Histone Deacetylase 6 Product Portfolio Table 52. Millennium Pharmaceuticals Inc Recent Developments Table 53. Medivir AB Company Information Table 54. Medivir AB Business Overview Table 55. Medivir AB Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Medivir AB Histone Deacetylase 6 Product Portfolio Table 57. Medivir AB Recent Developments Table 58. Karus Therapeutics Ltd Company Information Table 59. Karus Therapeutics Ltd Business Overview Table 60. Karus Therapeutics Ltd Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Karus Therapeutics Ltd Histone Deacetylase 6 Product Portfolio Table 62. Karus Therapeutics Ltd Recent Developments Table 63. Kancera AB Company Information Table 64. Kancera AB Business Overview Table 65. Kancera AB Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Kancera AB Histone Deacetylase 6 Product Portfolio Table 67. Kancera AB Recent Developments Table 68. HitGen LTD Company Information Table 69. HitGen LTD Business Overview Table 70. HitGen LTD Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. HitGen LTD Histone Deacetylase 6 Product Portfolio Table 72. HitGen LTD Recent Developments Table 73. Curis Inc Company Information Table 74. Curis Inc Business Overview Table 75. Curis Inc Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Curis Inc Histone Deacetylase 6 Product Portfolio Table 77. Curis Inc Recent Developments Table 78. Chong Kun Dang Pharmaceutical Corp Company Information Table 79. Chong Kun Dang Pharmaceutical Corp Business Overview Table 80. Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Product Portfolio Table 82. Chong Kun Dang Pharmaceutical Corp Recent Developments Table 83. Celgene Corp Company Information Table 84. Celgene Corp Business Overview Table 85. Celgene Corp Histone Deacetylase 6 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Celgene Corp Histone Deacetylase 6 Product Portfolio Table 87. Celgene Corp Recent Developments Table 88. Global Histone Deacetylase 6 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Histone Deacetylase 6 Sales by Region (2021-2026) & (K Units) Table 90. Global Histone Deacetylase 6 Sales Market Share by Region (2021-2026) Table 91. Global Histone Deacetylase 6 Sales by Region (2027-2032) & (K Units) Table 92. Global Histone Deacetylase 6 Sales Market Share by Region (2027-2032) Table 93. Global Histone Deacetylase 6 Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Histone Deacetylase 6 Revenue Market Share by Region (2021-2026) Table 95. Global Histone Deacetylase 6 Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Histone Deacetylase 6 Revenue Market Share by Region (2027-2032) Table 97. North America Histone Deacetylase 6 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Histone Deacetylase 6 Sales by Country (2021-2026) & (K Units) Table 99. North America Histone Deacetylase 6 Sales by Country (2027-2032) & (K Units) Table 100. North America Histone Deacetylase 6 Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Histone Deacetylase 6 Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Histone Deacetylase 6 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Histone Deacetylase 6 Sales by Country (2021-2026) & (K Units) Table 104. Europe Histone Deacetylase 6 Sales by Country (2027-2032) & (K Units) Table 105. Europe Histone Deacetylase 6 Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Histone Deacetylase 6 Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Histone Deacetylase 6 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Histone Deacetylase 6 Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Histone Deacetylase 6 Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Histone Deacetylase 6 Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Histone Deacetylase 6 Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Histone Deacetylase 6 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Histone Deacetylase 6 Sales by Country (2021-2026) & (K Units) Table 114. South America Histone Deacetylase 6 Sales by Country (2027-2032) & (K Units) Table 115. South America Histone Deacetylase 6 Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Histone Deacetylase 6 Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Histone Deacetylase 6 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Histone Deacetylase 6 Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Histone Deacetylase 6 Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Histone Deacetylase 6 Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Histone Deacetylase 6 Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Histone Deacetylase 6 Sales by Type (2021-2026) & (K Units) Table 123. Global Histone Deacetylase 6 Sales by Type (2027-2032) & (K Units) Table 124. Global Histone Deacetylase 6 Sales Market Share by Type (2021-2026) Table 125. Global Histone Deacetylase 6 Sales Market Share by Type (2027-2032) Table 126. Global Histone Deacetylase 6 Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Histone Deacetylase 6 Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Histone Deacetylase 6 Revenue Market Share by Type (2021-2026) Table 129. Global Histone Deacetylase 6 Revenue Market Share by Type (2027-2032) Table 130. Global Histone Deacetylase 6 Price by Type (2021-2026) & (US$/Unit) Table 131. Global Histone Deacetylase 6 Price by Type (2027-2032) & (US$/Unit) Table 132. Global Histone Deacetylase 6 Sales by Application (2021-2026) & (K Units) Table 133. Global Histone Deacetylase 6 Sales by Application (2027-2032) & (K Units) Table 134. Global Histone Deacetylase 6 Sales Market Share by Application (2021-2026) Table 135. Global Histone Deacetylase 6 Sales Market Share by Application (2027-2032) Table 136. Global Histone Deacetylase 6 Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Histone Deacetylase 6 Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Histone Deacetylase 6 Revenue Market Share by Application (2021-2026) Table 139. Global Histone Deacetylase 6 Revenue Market Share by Application (2027-2032) Table 140. Global Histone Deacetylase 6 Price by Application (2021-2026) & (US$/Unit) Table 141. Global Histone Deacetylase 6 Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Histone Deacetylase 6 Distributors List Table 145. Histone Deacetylase 6 Customers List Table 146. Histone Deacetylase 6 Industry Trends Table 147. Histone Deacetylase 6 Industry Drivers Table 148. Histone Deacetylase 6 Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Histone Deacetylase 6 Product Image Figure 5. Global Histone Deacetylase 6 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Histone Deacetylase 6 Market Size (2021-2032) & (US$ Million) Figure 7. Global Histone Deacetylase 6 Sales (2021-2032) & (K Units) Figure 8. Global Histone Deacetylase 6 Average Price (US$/Unit) & (2021-2032) Figure 9. ACY-738 Product Image Figure 10. Citarinostat Product Image Figure 11. CKD-504 Product Image Figure 12. HG-3001 Product Image Figure 13. MPT-0B291 Product Image Figure 14. Ricolinostat Product Image Figure 15. Others Product Image Figure 16. CNS Lymphoma Product Image Figure 17. Inflammation Product Image Figure 18. Colon Cancer Product Image Figure 19. Huntington Disease Product Image Figure 20. Others Product Image Figure 21. Global Histone Deacetylase 6 Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Histone Deacetylase 6, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Histone Deacetylase 6 Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Histone Deacetylase 6 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Histone Deacetylase 6 Sales by Region in 2025 Figure 27. Global Histone Deacetylase 6 Revenue by Region in 2025 Figure 28. North America Histone Deacetylase 6 Market Size by Country in 2025 Figure 29. North America Histone Deacetylase 6 Sales Market Share by Country (2021-2032) Figure 30. North America Histone Deacetylase 6 Revenue Market Share by Country (2021-2032) Figure 31. United States Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Histone Deacetylase 6 Market Size by Country in 2025 Figure 34. Europe Histone Deacetylase 6 Sales Market Share by Country (2021-2032) Figure 35. Europe Histone Deacetylase 6 Revenue Market Share by Country (2021-2032) Figure 36. Germany Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Histone Deacetylase 6 Market Size by Country in 2025 Figure 42. Asia Pacific Histone Deacetylase 6 Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Histone Deacetylase 6 Revenue Market Share by Country (2021-2032) Figure 44. China Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. China Taiwan Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Histone Deacetylase 6 Market Size by Country in 2025 Figure 53. South America Histone Deacetylase 6 Sales Market Share by Country (2021-2032) Figure 54. South America Histone Deacetylase 6 Revenue Market Share by Country (2021-2032) Figure 55. Mexico Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Brazil Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Histone Deacetylase 6 Market Size by Country in 2025 Figure 59. Middle East and Africa Histone Deacetylase 6 Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Histone Deacetylase 6 Revenue Market Share by Country (2021-2032) Figure 61. Turkey Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. UAE Histone Deacetylase 6 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Histone Deacetylase 6 Sales Market Share by Type (2021-2032) Figure 65. Global Histone Deacetylase 6 Revenue Market Share by Type (2021-2032) Figure 66. Global Histone Deacetylase 6 Price (US$/Unit) by Type (2021-2032) Figure 67. Global Histone Deacetylase 6 Sales Market Share by Application (2021-2032) Figure 68. Global Histone Deacetylase 6 Revenue Market Share by Application (2021-2032) Figure 69. Global Histone Deacetylase 6 Price (US$/Unit) by Application (2021-2032) Figure 70. Histone Deacetylase 6 Value Chain Figure 71. Histone Deacetylase 6 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Histone Deacetylase 6 Industry Opportunities and Challenges

Scope & coverage.

Types
  • ACY-738
  • Citarinostat
  • CKD-504
  • HG-3001
  • MPT-0B291
  • Ricolinostat
  • Others
Applications
  • CNS Lymphoma
  • Inflammation
  • Colon Cancer
  • Huntington Disease
  • Others
Companies covered
  • Merck & Co Inc
  • SK Biopharmaceuticals Co Ltd
  • Sigma-Tau SpA
  • Shuttle Pharmaceuticals LLC
  • Quimatryx SL
  • OnKure Inc
  • Millennium Pharmaceuticals Inc
  • Medivir AB
  • Karus Therapeutics Ltd
  • Kancera AB
  • HitGen LTD
  • Curis Inc
  • Chong Kun Dang Pharmaceutical Corp
  • Celgene Corp

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Histone Deacetylase 6 Market Size (2021-2032)
  4. 2.2.2 Global Histone Deacetylase 6 Sales (2021-2032)
  5. 2.2.3 Global Histone Deacetylase 6 Market Average Price (2021-2032)
  6. 2.3 Histone Deacetylase 6 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 ACY-738
  9. 2.3.3 Citarinostat
  10. 2.3.4 CKD-504
  11. 2.3.5 HG-3001
  12. 2.3.6 MPT-0B291
  13. 2.3.7 Ricolinostat
  14. 2.3.8 Others
  15. 2.4 Histone Deacetylase 6 by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 CNS Lymphoma
  18. 2.4.3 Inflammation
  19. 2.4.4 Colon Cancer
  20. 2.4.5 Huntington Disease
  21. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Histone Deacetylase 6 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Histone Deacetylase 6 Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Histone Deacetylase 6 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Histone Deacetylase 6 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Histone Deacetylase 6 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Histone Deacetylase 6, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Histone Deacetylase 6, Product Type & Application
  8. 3.8 Global Manufacturers of Histone Deacetylase 6, Established Date
  9. 3.9 Global Histone Deacetylase 6 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck & Co Inc
  2. 4.1.1 Merck & Co Inc Company Information
  3. 4.1.2 Merck & Co Inc Business Overview
  4. 4.1.3 Merck & Co Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck & Co Inc Histone Deacetylase 6 Product Portfolio
  6. 4.1.5 Merck & Co Inc Recent Developments
  7. 4.2 SK Biopharmaceuticals Co Ltd
  8. 4.2.1 SK Biopharmaceuticals Co Ltd Company Information
  9. 4.2.2 SK Biopharmaceuticals Co Ltd Business Overview
  10. 4.2.3 SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Product Portfolio
  12. 4.2.5 SK Biopharmaceuticals Co Ltd Recent Developments
  13. 4.3 Sigma-Tau SpA
  14. 4.3.1 Sigma-Tau SpA Company Information
  15. 4.3.2 Sigma-Tau SpA Business Overview
  16. 4.3.3 Sigma-Tau SpA Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sigma-Tau SpA Histone Deacetylase 6 Product Portfolio
  18. 4.3.5 Sigma-Tau SpA Recent Developments
  19. 4.4 Shuttle Pharmaceuticals LLC
  20. 4.4.1 Shuttle Pharmaceuticals LLC Company Information
  21. 4.4.2 Shuttle Pharmaceuticals LLC Business Overview
  22. 4.4.3 Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Product Portfolio
  24. 4.4.5 Shuttle Pharmaceuticals LLC Recent Developments
  25. 4.5 Quimatryx SL
  26. 4.5.1 Quimatryx SL Company Information
  27. 4.5.2 Quimatryx SL Business Overview
  28. 4.5.3 Quimatryx SL Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Quimatryx SL Histone Deacetylase 6 Product Portfolio
  30. 4.5.5 Quimatryx SL Recent Developments
  31. 4.6 OnKure Inc
  32. 4.6.1 OnKure Inc Company Information
  33. 4.6.2 OnKure Inc Business Overview
  34. 4.6.3 OnKure Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 OnKure Inc Histone Deacetylase 6 Product Portfolio
  36. 4.6.5 OnKure Inc Recent Developments
  37. 4.7 Millennium Pharmaceuticals Inc
  38. 4.7.1 Millennium Pharmaceuticals Inc Company Information
  39. 4.7.2 Millennium Pharmaceuticals Inc Business Overview
  40. 4.7.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Product Portfolio
  42. 4.7.5 Millennium Pharmaceuticals Inc Recent Developments
  43. 4.8 Medivir AB
  44. 4.8.1 Medivir AB Company Information
  45. 4.8.2 Medivir AB Business Overview
  46. 4.8.3 Medivir AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Medivir AB Histone Deacetylase 6 Product Portfolio
  48. 4.8.5 Medivir AB Recent Developments
  49. 4.9 Karus Therapeutics Ltd
  50. 4.9.1 Karus Therapeutics Ltd Company Information
  51. 4.9.2 Karus Therapeutics Ltd Business Overview
  52. 4.9.3 Karus Therapeutics Ltd Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Karus Therapeutics Ltd Histone Deacetylase 6 Product Portfolio
  54. 4.9.5 Karus Therapeutics Ltd Recent Developments
  55. 4.10 Kancera AB
  56. 4.10.1 Kancera AB Company Information
  57. 4.10.2 Kancera AB Business Overview
  58. 4.10.3 Kancera AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Kancera AB Histone Deacetylase 6 Product Portfolio
  60. 4.10.5 Kancera AB Recent Developments
  61. 4.11 HitGen LTD
  62. 4.11.1 HitGen LTD Company Information
  63. 4.11.2 HitGen LTD Business Overview
  64. 4.11.3 HitGen LTD Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 HitGen LTD Histone Deacetylase 6 Product Portfolio
  66. 4.11.5 HitGen LTD Recent Developments
  67. 4.12 Curis Inc
  68. 4.12.1 Curis Inc Company Information
  69. 4.12.2 Curis Inc Business Overview
  70. 4.12.3 Curis Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Curis Inc Histone Deacetylase 6 Product Portfolio
  72. 4.12.5 Curis Inc Recent Developments
  73. 4.13 Chong Kun Dang Pharmaceutical Corp
  74. 4.13.1 Chong Kun Dang Pharmaceutical Corp Company Information
  75. 4.13.2 Chong Kun Dang Pharmaceutical Corp Business Overview
  76. 4.13.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Product Portfolio
  78. 4.13.5 Chong Kun Dang Pharmaceutical Corp Recent Developments
  79. 4.14 Celgene Corp
  80. 4.14.1 Celgene Corp Company Information
  81. 4.14.2 Celgene Corp Business Overview
  82. 4.14.3 Celgene Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Celgene Corp Histone Deacetylase 6 Product Portfolio
  84. 4.14.5 Celgene Corp Recent Developments
5 Global Histone Deacetylase 6 Market Scenario by Region
  1. 5.1 Global Histone Deacetylase 6 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Histone Deacetylase 6 Sales by Region: 2021-2032
  3. 5.2.1 Global Histone Deacetylase 6 Sales by Region: 2021-2026
  4. 5.2.2 Global Histone Deacetylase 6 Sales by Region: 2027-2032
  5. 5.3 Global Histone Deacetylase 6 Revenue by Region: 2021-2032
  6. 5.3.1 Global Histone Deacetylase 6 Revenue by Region: 2021-2026
  7. 5.3.2 Global Histone Deacetylase 6 Revenue by Region: 2027-2032
  8. 5.4 North America Histone Deacetylase 6 Market Facts & Figures by Country
  9. 5.4.1 North America Histone Deacetylase 6 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Histone Deacetylase 6 Sales by Country (2021-2032)
  11. 5.4.3 North America Histone Deacetylase 6 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Histone Deacetylase 6 Market Facts & Figures by Country
  15. 5.5.1 Europe Histone Deacetylase 6 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Histone Deacetylase 6 Sales by Country (2021-2032)
  17. 5.5.3 Europe Histone Deacetylase 6 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Histone Deacetylase 6 Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Histone Deacetylase 6 Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Histone Deacetylase 6 Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Histone Deacetylase 6 Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Histone Deacetylase 6 Market Facts & Figures by Country
  35. 5.7.1 South America Histone Deacetylase 6 Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Histone Deacetylase 6 Sales by Country (2021-2032)
  37. 5.7.3 South America Histone Deacetylase 6 Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Histone Deacetylase 6 Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Histone Deacetylase 6 Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Histone Deacetylase 6 Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Histone Deacetylase 6 Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Histone Deacetylase 6 Sales by Type (2021-2032)
  2. 6.1.1 Global Histone Deacetylase 6 Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Histone Deacetylase 6 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Histone Deacetylase 6 Revenue by Type (2021-2032)
  5. 6.2.1 Global Histone Deacetylase 6 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Histone Deacetylase 6 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Histone Deacetylase 6 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Histone Deacetylase 6 Sales by Application (2021-2032)
  2. 7.1.1 Global Histone Deacetylase 6 Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Histone Deacetylase 6 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Histone Deacetylase 6 Revenue by Application (2021-2032)
  5. 7.2.1 Global Histone Deacetylase 6 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Histone Deacetylase 6 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Histone Deacetylase 6 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Histone Deacetylase 6 Value Chain Analysis
  2. 8.1.1 Histone Deacetylase 6 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Histone Deacetylase 6 Production Mode & Process
  5. 8.2 Histone Deacetylase 6 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Histone Deacetylase 6 Distributors
  8. 8.2.3 Histone Deacetylase 6 Customers
9 Global Histone Deacetylase 6 Analyzing Market Dynamics
  1. 9.1 Histone Deacetylase 6 Industry Trends
  2. 9.2 Histone Deacetylase 6 Industry Drivers
  3. 9.3 Histone Deacetylase 6 Industry Opportunities and Challenges
  4. 9.4 Histone Deacetylase 6 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst